Effect of Pitavastatin on the coronary endothelial dysfunction after PCI with DES (Drug-eluting stent)

Trial Profile

Effect of Pitavastatin on the coronary endothelial dysfunction after PCI with DES (Drug-eluting stent)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Nov 2011

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis; Hypercholesterolaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Nov 2011 Status changed from not yet recruiting to recruiting as reported byUniversity Hospital Medical Information Network - Japan record.
    • 26 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top